United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Allergan to acquire Bonti in strategic $195m deal to expand medical aesthetics pipeline Irish pharmaceutical giant Allergan has announced its acquisition of Bonti, a U.S.-based aesthetic company specializing in fast-acting neurotoxin… bypharmanewsdailySeptember 16, 2018
